an investigational growth-hormone secretagogue that was never FDA-approved
In the first year following diagnosis, we found increased cumulative incidence risk ratios in a number of outcomes including: - Any mental, behavioural, or neurodevelopmental disorder 1.96 (1.93 - 1.99) - Postpartum depression 2.70 (2.61 - 2.79) - Eating disorders 2.06 (1.85 - 2.89) - PTSD 1.77 (1.69 - 1.86) We also saw significantly increased risk in rare but serious outcomes such as: - Wernicke's encephalopathy 2.39 (1.25 - 4.56) - Puerperal psychosis 1.80 (1.48 - 2.20) Interestingly, cases of hyperemesis gravidarum with metabolic disturbance displayed a significantly lower risk of any depression and postpartum depression compared with those without metabolic disturbance
Memory loss, brain fog, and difficulty concentrating are all symptoms of age-related cognitive degeneration
Heres how it may present: Neurological & Cognitive Brain fog Headaches or migraines Anxiety or panic attacks Insomnia Light or sound sensitivity Dizziness or balance problems Respiratory Shortness of breath Asthma-like symptoms Nasal congestion Frequent throat clearing Chronic cough Gastrointestinal Bloating Nausea or vomiting Diarrhea or constipation Acid reflux Abdominal pain Food intolerances Cardiovascular Heart palpitations Low blood pressure Flushing or facial redness Dizziness on standing (POTS) Musculoskeletal Joint pain Muscle aches Bone pain Dermatological Hives Itching without rash Rashes or eczema Dermatographia (skin writing) Systemic Temperature dysregulation Sensitivity to smells, chemicals, or stress Reactions to medications, supplements, or anesthesia Common Triggers of Mast Cell Degranulation People with MCAS often react to otherwise harmless stimuli
Absorbed through the digestive system, which may reduce bioavailability
